(Q34326172)

1 August 2017

1 reference

title

Gene therapy for human severe combined immunodeficiencies. (English)

1 reference

1 August 2017

0 references

Cavazzana-Calvo M

1 reference

1 August 2017

Fischer A

1 reference

1 August 2017

Hacein-Bey S

series ordinal

1 reference

1 August 2017

Le Deist F

series ordinal

1 reference

1 August 2017

de Saint Basile G

series ordinal

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

1-4

1 reference

Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

The potential for therapy of immune disorders with gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Gene therapy of severe combined immunodeficiencies.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Gene therapy using hematopoietic stem cells: Sisyphus approaches the crest

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Observations of the carrier state in hamsters infected with Leptospira interrogans serotype pomona

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Lack of dominant-negative effects of a truncated gamma(c) on retroviral-mediated gene correction of immunodeficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Issues in the manufacture and transplantation of genetically modified hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

Progress in the use of gene transfer methods to treat genetic blood diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900175-3

7 January 2021

10.1016/S1074-7613(01)00175-3

Identifiers

DOI

1 reference

1 August 2017

1 reference